Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Saved in:
| Title: | Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis. |
|---|---|
| Authors: | Lee YC; Department of Oncology, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan; Department of Internal Medicine, National Cheng Kung University, Tainan, Taiwan., Hsieh CC; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA., Lee YL; Department of Oncology, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan., Li CY; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. Electronic address: cyli99@mail.ncku.edu.tw. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Sep; Vol. 18 (9), pp. 558-568. Date of Electronic Publication: 2018 Jun 08. |
| Publication Type: | Journal Article; Meta-Analysis; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2018.06.004 |
